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Acute secondary neuronal cell death, as seen in neurodegenerative disease, cerebral ischemia 
(stroke) and traumatic brain injury (TBI), drives spreading neurotoxicity into surrounding, 
undamaged, brain areas. This spreading toxicity occurs via two mechanisms, synaptic toxicity 
through hyperactivity, and excitotoxicity following the accumulation of extracellular glutamate. 
To date, there are no fast-acting therapeutic tools capable of terminating secondary spreading 
toxicity within a time frame relevant to the emergency treatment of stroke or TBI patients. Here, 
using hippocampal neurons (DIV 15-20) cultured in microfluidic devices in order to deliver a 
localized excitotoxic insult, we replicate secondary spreading toxicity and demonstrate that this 
process is driven by GluN2B receptors. In addition to the modeling of spreading toxicity, this 
approach has uncovered a previously unknown, fast acting, GluN2A-dependent neuroprotective 
signaling mechanism.  This mechanism utilizes the innate capacity of surrounding neuronal 
networks to provide protection against both forms of spreading neuronal toxicity, synaptic 
hyperactivity and direct glutamate excitotoxicity. Importantly, network neuroprotection against 
spreading toxicity can be effectively stimulated after an excitotoxic insult has been delivered, 
and may identify a new therapeutic window to limit brain damage. 
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Introduction 
During the development of the central nervous system, competition for synapse formation and 
early patterns of QHXURQDOQHWZRUNDFWLYLW\DUHUHTXLUHGIRUQHXURQVWR³ILUHWRJHWKHUDQGZLUH
WRJHWKHU´GULYLQJWKHIRUPDWLRQRIIXQFWLRQDOQHXURQDOQHWZRUNV(1,2,3).  Once established, 
neuronal survival is conditional upon continued participation in neuronal network activity.  
However, following cerebral ischemia (stroke) or traumatic brain injury (TBI), synapsed neurons 
in the surrounding penumbral region are at high risk from spreading depolarizations(4) and 
elevated extracellular glutamate released by cell lysis and transporter reversal(5), leading to 
NMDA receptor dependent synaptic toxicity(5,6,7) and excitotoxicity(5,7,8,9,10). Paradoxically, the 
use of NMDA receptor antagonists as neuroprotectants actually exacerbates brain injury(11,12) due 
to inhibition of essential pro-survival signaling that occurs through these receptors(10,13,14). To 
date, successful protection of neurons against damage can be achieved by the use of 
preconditioning paradigms, where low-level stimulation(13,14,15,16,17), or exercise(18,19), can induce 
a neuroprotective state to subsequent larger insults. Unfortunately, the duration (days) of 
preconditioning required for neuroprotection to develop limits its clinical value.  
Given that damage from a lesion does not spread uncontrollably to consume the entire brain, 
combined with our knowledge that synaptic neurotransmission can be protective(10,13,14), it is 
reasonable to assume that neuronal networks may possess an innate capacity to restrict damage 
in vivo. However, a problem in studying spreading toxicity to naïve neurons in vivo is the 
difficulty in separating the initial lesion from its downstream consequences. We have achieved 
this separation using an in vitro model based on a microfluidic channel network, where multiple 
neuron populations, that are environmentally isolated but synaptically connected, are cultured 
and their microenvironment precisely manipulated(20). Using this approach, we can isolate 
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activity-dependent spreading toxicity from direct glutamate excitotoxicity and use this to model 
and investigate potential neuroprotective network activity. 
 
Results 
Functional synaptic communication between environmentally-isolated neuronal networks. 
In order to isolate secondary spreading toxicity from the primary excitotoxic insult, we adopted 
the use of a microfluidic system having five cell culture chambers serially interconnected by 500 
ȝPORQJPLFURFKDQQHOV (Fig. 1a).  Hippocampal neurons were cultured in each chamber and 
synaptically connected via axons traversing the microchannels (Fig. 1b). A protocol (detailed in 
Materials and Methods) was developed to ensure that, during exposure of an insult in the desired 
chamber, no cross-contamination occurred into surrounding chambers. To validate the protocol, 
DIOXRUHVFHLQVXVSHQVLRQZDVDGGHGWRWKHµGLUHFW¶LQVXOWHGFKDPEHUFKDPEHUµ¶)LJ1a) and its 
diffusion monitored via epifluoreVFHQFHPLFURVFRS\DFURVVDILHOGRIYLHZVSDQQLQJWKHµGLUHFW¶
DQGµLQGLUHFW¶FKDPEHUVDWILYHGLIIHUHQWORFDWLRQV)LJ1c). The fluorescence signals show that 
an almost constant intensity is achieved at the site of delivery, with no fluorescence detected in 
the microchannels or surrounding chambers(20).  
Prior to microfluidic experimentation, we established the neuronal responses to excitotoxicity. 
Hippocampal neuron-seeded coverslips were exposed to various concentrations of glutamate 
(with glycine as a co-agonist) for 1 hour, and stained with Hoeschst-33342 (4.5 ȝ0DQG
SURSLGLXPLRGLGHȝ0KRXUVODWHUWRGHWHUPLQHWKHSHUFHQWDJHRIOLYHGHDGFHOOV
UHVSHFWLYHO\([FLWRWR[LFLW\WRJOXWDPDWHRFFXUUHGDWȝ0**FHOO
GHDWK3ZLWKȝ0EHLQJVXEWR[LF**FHll death, P > 0.05).  As 
reported previously(15), following an excitotoxic challenge (100 GG) to a single neuronal 
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chamber in the microfluidic device, a rapid influx of Ca2+ is observed, followed by a prolonged 
raised basal level (the latent period) and ultimately to delayed Ca2+ deregulation (Fig. 1d, upper 
panel, black trace). Confirming neuronal communication exists between chambers, a 
consequential Ca2+ response with rapid spiking activity occurs in downstream chambers (Fig. 1d, 
lower panel, red trace). These downstream signals are abolished in the absence of action 
SRWHQWLDOILULQJWHWURGRWR[LQ77;ȝ0)LJ1d, lower panel, blue trace). 
 
Glutamate-induced spreading neurotoxicity through neuronal networks.  
Mitochondrial depolarization, an early indicator of excitotoxicity(15), occurs in the chamber 
directly exposed to 100 GG (Fig. 2a, direct), but despite the Ca2+ spikes present in the 
downstream neuronal chambers, mitochondrial depolarization does not spread (Fig. 2a, indirect). 
This suggests a localized excitotoxic insult evokes a spreading hyperactivity to a wider neuronal 
network(4,5,6,7). To explore whether toxicity spreads in the absence of spreading extracellular 
glutamate, an excitotoxic insult (100 GG, 1 hour) was delivered to the central chamber only (Fig. 
2b, chamber 0) and morphological changes (MAP2 staining) and cell death determined in all 5 
chambers after 24 hours. As expected, extensive dendritic beading and neuronal cell death was 
observed in the directly exposed central chamber (62.84 ± 13.28% cell death, subsequently 
normalized to 100% for clarity). Dendrotoxicity and cell death spread from the central chamber 
to connected neurons in both adjacent (-1/+1) chambers (85.6 ± 19.78% / 77.73 ± 25.1% 
respectively) and into both distal (-2/+2) chambers (75.15 ± 22.84% / 68.35 ± 17.28%, 
respectively) (Fig. 2b, white bars), as compared to control saline-treated devices (UT, 30.44 ± 
,QWKHDEVHQFHRIV\QDSWLFQHXURWUDQVPLVVLRQ77;ȝ0VSUHDGLQJWR[LFLW\LV
abolished in all downstream chambers (-1/+1; 42.55 ± 5.56% / 38.61 ± 3.66% and -2/+2; 39.08 ± 
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4.72% / 40.07 ± 9.14%, respectively. Fig. 2b, black bars). To examine the effect of a failure of 
glutamate transporter function, as occurs under ischemic conditions, we included a glutamate 
transporter blocker (TFB-TBOA) to chambers on one side of the excitotoxic insult. At a 
concentration that specifically blocks glial glutamate transporters ȝ0RUZKHQDOO
JOXWDPDWHWUDQVSRUWHUVDUHEORFNHGȝ0QRWVKRZQFHOOGHDWKIURPVSUHDGLQJWR[LFLW\LV
exacerbated (Fig. 2c). Selective blockade of downstream NMDA receptors with MK 801 (10 
ȝ0UHWXUQVWKHVSUHDGLQJ&D2+ signal to baseline in the indirect chambers (Fig. 2d), and 
abolishes spreading toxicity (47.32 ± 7.55%, Fig. 2e). More selectively, spreading toxicity is 
DEROLVKHGLQWKHSUHVHQFHRIWKH*OX1%DQWDJRQLVW,IHQSURGLOȝ0EXWQRW
the GluN2A antagonist, NVP-AAM0ȝ0)LJ2f), indicating that 
spreading toxicity from a localized excitotoxic insult into downstream neuronal networks, occurs 
via GluN2B receptors.  
 
Spatiotemporal spreading neuroprotection in connected networks.  
Subtoxic insults have been reported to exert a protective preconditioning effect that protects 
neurons against subsequent excitotoxic challenges(13,14,15,16,17). In keeping with this, a 1 hour 
treatment of 50 GG is protective against a direct excitotoxic insult (100 GG, 1 hour) delivered 
after 24 hours, but protection is not established immediately (Fig. 3a). This slow-onset 
protection requires ongoing neurotransmission, as it is blocked by TTX (Fig. 3a). Therefore, we 
questioned whether a preconditioning stimulus (50 GG) could also transmit protection along a 
neuronal network. In keeping with this, preconditioning transmits a downstream Ca2+ response 
(50 GG, Fig. 3b, black traces) in surrounding neuronal networks, although it does not produce 
the prolonged Ca2+ spiking activity generated by an excitotoxic insult (Fig. 1d), but does 
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stimulate a raised Ca2+ level that slowly returns to baseline (Fig. 3b, red trace). Interestingly, 
despite preconditioning being ineffective when delivered just prior to an excitotoxic insult (Fig. 
3a), it can transmit a fast acting protective signal to downstream chambers, where neurons are 
protected against spreading toxicity initiated from a subsequent upstream excitotoxic insult 
delivered immediately afterwards (Fig. 3c). 
Spreading toxicity during stroke or TBI in vivo is likely to be a consequence of both synaptic 
toxicity through hyperactivity and excitotoxicity from extracellular accumulation of glutamate(5). 
To address the capacity of this fast acting network signal to also protect against a subsequent 
direct excitotoxic insult, a preconditioning stimulus (50 GG, 1 hour) was delivered to the central 
chamber, followed immediately by an excitotoxic insult (100 GG, 1 hour) to all five chambers. 
As seen previously (Fig. 3a/c), no protection was afforded to the directly preconditioned 
chamber (Fig. 3d, chamber 0). However, the spreading protective signal is capable of delivering 
a fast onset (<1 hour) protection against a direct excitotoxic insult (70.87 ± 16.47% and 58.29 ± 
13.74% cell death in -1/+1 and -2/+2, respectively) (Fig. 3d, black bars). This fast acting 
network protective signaling is also activity-dependent, as it is blocked by TTX (111.53 ± 
11.85% and 112.68 ± 15.51% cell death in -1/+1 and -2/+2, respectively) (Fig. 3d, white bars), 
and prevents excitotoxicity-induced delayed Ca2+ deregulation and mitochondrial depolarization 
(Fig. 3e-f). In contrast to the role of GluN2B NMDA receptors in spreading toxicity (Fig. 2f), 
GluN2A receptors are responsible for this spreading protection as it is blocked by NVP-
$$0ȝ0FHOOGHDWKEXWQRW,IHQSURGLOȝ0FHOO
death) (Fig. 3g).  
It has been reported that GABAA receptor activity can attenuate NMDA-mediated 
excitotoxicity, whilst GABAB receptor activity is ineffective
(21). In support of these findings, we 
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REVHUYHWKDWGXULQJDQH[FLWRWR[LFLQVXOWPXVFLPROȝ0 DQGGLD]HSDPȝ0, but not 
EDFORIHQȝ0LVQHXURSURWHFWLYHDJDLQVW excitotoxicity (Fig. 4a). Interestingly however, 
baclofen becomes neuroprotective against excitotoxicity if present prior to (1 hour) and during 
the insult (Fig. 4a). We therefore investigated whether GABAA and GABAB receptor inhibitory 
activity can counter spreading toxicity. An excitotoxic insult was delivered to the central 
chamber (100 GG, 1 hour), while GABAA or GABAB receptors were VWLPXODWHGȝ0
muscimolȝ0GLD]HSDm RUȝ0EDFORIHQLQGRZQVWUHDPFKDPEHUV,Qall cases, 
spreading toxicity was abolished (muscimol, 43.72 ± 3.89%, diazepam xx ± xx%, and baclofen, 
48.04 ± 0.3%) (Fig. 4b), when compared to saline-treated cells (Fig. 4b, white bar). In support of 
a role for increased inhibitory tone in quenching excitatory signaling and spreading toxicity, 
either GABAA or GABAB receptor activation (muscimol or baclofen, respectively) can 
terminate the rapid downstream Ca2+ spiking activity characteristic of a spreading excitotoxic 
challenge (Fig. 4c), further indicating that spreading hyperactivity is neurotoxic. However, 
protection against subsequent excitotoxicity is only blocked by GABAB receptor inhibition (1 
ȝ0&*3-55845, 90.21 ± 2.24%) with little impact on protection by GABAA receptor inhibition 
ȝ0ELFXFXOOLQH)LJ4d). These data suggest therefore, that a localized 
preconditioning stimulus initiates the recruitment of GABAB receptor inhibitory neuroprotection 
in surrounding neurons against subsequent direct excitotoxic challenges. 
 
Recruiting network neuroprotection after an excitotoxic insult.  
To investigate the temporal effectiveness of this rapid network protection, we explored whether 
neuroprotection could be achieved with shorter durations prior to an insult, or even post-insult. 
We find that an equal level of network protection is still possible when the protective stimulus 
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(50 GG) is reduced to just 30 minutes (Fig. 5a). Furthermore, network protection is stable for at 
least 1 hour, as determined by delaying the excitotoxic insult (Fig. 5b). However, when the 
interval between the protective stimulus and toxic insult was expanded to 4 hours, no network 
protection is evident (Fig. 5c). This suggests network protection may be a transient phenotype, 
recruited to resist the brunt of excitotoxic damage, but which cannot last indefinitely in the 
continued presence of extracellular glutamate. 
Of particular relevance to an emergency clinical situation of TBI, or following a stroke, would 
be the ability for a neuroprotective strategy to be effective after the onset of damage. Therefore, 
we investigated whether the protection could be achieved after a localised excitotoxic insult had 
been delivered (postconditioning). Interestingly, a protective stimulus, delivered an hour after a 
localized excitotoxic insult, can still afford full protection against spreading toxicity (36.44 ± 
10.81% and 35.39 ± 9.67% cell death in -2/-1 and 1/2, respectively, Fig. 5d gray bars), 
suggesting that downstream neurons surrounding a lesion are not committed to die during this 
insult period. However, little protection against the direct excitotoxic challenge is evident (85.79 
± 11.48% cell death in chamber 0) in this time period. In contrast, when the protective stimulus 
was delivered sooner (after 30 min), significant neuroprotection is also observed (60.25 ± 
15.32%) against the direct excitotoxic challenge (Fig. 5e). When the protection was delivered 
after just 10 minutes, full protection is observed (50.94 ± 9.17%) against the lesion in all 
chambers (Fig. 5f). This vanishing therapeutic window against direct ongoing excitotoxic 
damage most likely represents the time taken for cells to undergo terminal delayed Ca2+ 
deregulation (Fig. 1d). 
Interestingly, although an excitotoxic insult clearly spreads neurotoxicity, this diminishes as it 
progresses (Fig. 2b, white bars), suggesting either an attenuation of the toxic signal over 
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distance, or a recruitment of neuroprotective signaling (or both). We demonstrate the existence 
of a spreading neuroprotective signal, emanating from an excitotoxic insult, that confers network 
resistance to a subsequent direct excitotoxic challenge (Fig. 6), as would occur in vivo with 
elevated glutamate levels. Therefore, neuroprotective signaling may occur naturally within 
neuronal networks in vivo in response to an insult and will ultimately dominate over spreading 
toxicity. This mechanism may contribute to why an excitotoxic lesion in vivo does not spread 
uncontrollably to consume the entire brain, and our study reinforces how a blanket NMDA 
receptor blockade will exacerbate network damage(11) by preventing innate neuroprotective 
network signaling. Instead, therapeutic approaches to promote this innate spreading 
neuroprotective network activity may effectively terminate ongoing secondary neuronal toxicity.   
 
Discussion 
Using hippocampal neurons cultured in multi-chambered microfluidic devices it is possible to 
produce environmentally-isolated neuronal populations that are synaptically interconnected(20). 
Using this model, an isolated excitotoxic insult may be delivered to a neuronal network and 
spreading toxicity monitored. We observe that downstream non-insulted neurons may succumb 
to secondary spreading neuronal toxicity through GluN2B-mediated hyperactivity.  In addition to 
the modeling of spreading toxicity, akin to a neuronal network protection racket, we demonstrate 
that neuronal networks offer a previously unknown, fast acting GluN2A-dependent 
neuroprotective signaling mechanism. This mechanism utilizes the innate capacity of 
surrounding neuronal networks to quench excitation, through the recruitment of GABAB 
receptors, to provide protection against excitotoxicity. Importantly, network neuroprotection 
against spreading toxicity can be effectively stimulated after an excitotoxic insult has been 
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delivered, and may identify a new therapeutic window to limit on-going brain damage in 
conditions of chronic (neurodegenerative disease) or acute (stroke, TBI) neuronal injury. 
Stroke and TBI are leading causes of death and long term disability in adults worldwide, with 
patients often unable to return to work, and requiring around the clock care.  Rapid therapeutic 
intervention is key to reducing mortality and improving the prognosis by curtailing the extent of 
brain damage. Beyond the lesioned area of the brain lies an area of increased vulnerability, the 
penumbra. Within this penumbral region, neurons may be exposed to synaptic hyperactivity(6,7),  
toxic spreading depolarization(4,22,23) and high levels of extracellular glutamate, leading to 
excitotoxicity(4,8,9,15). Such a cascade of toxicity could consume entire networks, but is naturally 
restricted. 
A number of forms of neuroprotection have been identified to date(10,13,14,16,17,18,19) which may 
offer great promise in the treatment of chronic conditions, where disease progression is slow, 
however, protective mechanisms involving gene regulation require days to become effective 
(preconditioning) and so have limited therapeutic value in the emergency treatment of stroke and 
TBI patients.  The direct approach of using NMDA receptor antagonists to block ongoing 
excitotoxicity has failed due to the paradoxical neuroprotective role of NMDA receptors. 
However, the uncoupling of NMDA receptors from cell death pathways hold great promise and 
may be selective against pathological NMDA receptor activity, leaving neuroprotective 
signalling intact(24,25,26). To date, there are no effective strategies to prevent neurotoxicity 
spreading into surrounding neuronal networks. Therefore, current research has focused on 
promoting brain recovery(27,28,29). Here we demonstrate a neuroprotective role for the use of 
benzodiazepines following a stroke. In contrast however, a recent meta-analysis has concluded 
that the potentiation of GABAA receptor activity is not effective (Liu 2014). Indeed, the 
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functional recovery of network activity is compromised by increased extrasynaptic GABAA 
receptor activity for weeks (Clarkson 2010). However, inhibition of this extrasynaptic activity 
immediately after the onset of stroke increases the infarct size, suggesting a GABAergic 
neuroprotective role immediately after a stroke. This is further supported by the findings that 
clomethiazole is effective at reducing ischemic damage if applied rapidly (Sydserff et al 1995, 
Marshall 1999), but not if delayed (Marshall 2000). Therefore, a strategic transient (hours) 
potentiation of GABAA receptors (Aerden 2004), followed by a prolonged (weeks) inhibition of 
extrasynaptic GABAA receptors may be an optimal neuroprotective strategy. 
This study has demonstrated that a therapeutic opportunity to curtail spreading toxicity may exist 
by harnessing the innate capacity of neuronal networks to block toxicity. The recruitment of this 
neuroprotection occurs in a timescale significantly faster (< hour) than classical preconditioning 
(days), where upregulation of pro-survival genes is required to boost antioxidant defence, 
suppress caspase activation and promote mitochondrial health(10,14). Moreover, neuroprotection 
from preconditioning is persistent, lasting for several days (Xu, 2002, Wang 2006), while the 
fast-acting neuroprotection demonstrated in this study is transient, lasting for less than 4 hours. 
Together, this indicates that the network recruitment of neuroprotection discovered here is 
temporally distinct from the previously identified preconditioning pathways. However, it remains 
possible that normal preconditioning is tempered by the coexistence of the opposing actions of 
extrasynaptic NMDA receptors (Hardingham 2002), and a more rapid onset of preconditioning 
signalling may be possible. 
The spreading network protection identified here, reduces deleterious Ca2+ influx into neurons, 
prevents subsequent mitochondrial depolarization and excitotoxicity-induced delayed Ca2+ 
deregulation, and is effective against both synaptic hyperactivity and extrasynaptic 
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excitotoxicity. We demonstrate that in response to an excitotoxic lesion, both toxic and 
protective signals permeate through a network concomitantly, but as they progress, 
neuroprotection untimely dominates, and offers a mechanistic explanation of why a lesion does 
not spread uncontrollably to engulf the entire brain.  The point at which the neuroprotective 
network signalling dominates may also contribute to defining the extent of the penumbral region 
that is susceptible to excitotoxic damage. These data are in keeping with previous studies which 
report a neuroprotective role for enhanced (synaptic) GluN2A and a neurotoxic role for 
(extrasynaptic) GluN2B receptors in mature neurons(8,10,13,14). 
A new potential pharmacological opportunity to limit neuronal damage is indicated by the 
requirement for GABAB receptor function in delivering protection against subsequent 
excitotoxicity. However, an alternative therapeutic strategy to pharmacological manipulation 
may be to provide direct transcranial neuronal stimulation to connected brain regions. There is a 
therapeutic precedence for the use of brain stimulation in the treatment of the dysfunctional 
brain. A number of optical, electrical and magnetic approaches exist(28,30,31), with 
electroconvulsive therapy being used for decades to treat depression and more recently proposed 
as a treatment for neurodegenerative disease patients(32). Recent clinical trial evidence suggests 
that non-convulsive electrical stimulation may also be effective(33), transcranial current 
stimulation post stroke may improve motor recovery(34) and the extension of acupuncture to 
include the potential of electrostimulation (electroacupuncture) appears to have beneficial effects 
for acute ischemic stroke(35). 
Interestingly, in a model of Huntington disease, the synaptic/extrasynaptic NMDA receptor 
balance is critical in regulating mutant Huntingtin toxicity(36) and dysregulation contributes to 
disease onset and progression(37).  Additionally, a recent report has identified a role for ȕ-amyloid 
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in increasing the expression of dendritic GluN2B, whilst decreasing the synaptic level of 
*OX1$LQPRGHORI$O]KHLPHU¶VGLVHDVH(38). Therefore, it may be possible that increased 
vulnerability to, or enhancement of, innate GluN2B-mediated spreading network toxicity and/or 
limitation of innate GluN2A-mediated spreading network neuroprotection, as revealed in this 
study, contributes to the progressive loss of neurons found in chronic neurodegenerative disease, 
and reflects a common mechanism of dysfunction in the brain. It may therefore be possible, 
through stimulating neuronal network protective signalling, to provide a common treatment for 
these conditions.  Future study will be required to elucidate whether the protective mechanisms 
identified in this study are efficacious in these chronic disease states. 
In summary, we demonstrate the value of microfluidics in the study of neuronal network 
communication that is relevant to pathological conditions of rapid neurotoxicity (stroke, TBI) as 
well as conditions of network dysfunction (epileptiform activity, spreading depolarizations, 
neurodegenerative disease).  We reveal a novel form of rapid neuroprotective signalling within 
networks, relying on the innate capacity of neurons to quench excitation. In previous studies, 
such network activity may have been overwhelmed by the initiation of global excitotoxic 
mechanisms.  Harnessing the full potential of this innate network neuroprotective capacity may 
open the doors to many therapeutic opportunities. 
 
Materials and Methods 
Device preparation 
Microfluidic devices were fabricated in polydimethylsiloxane (PDMS) using standard soft 
lithography techniques.  Silicon masters were produced using a double layer of SU8 photoresist 
(3000 series, MicroChem, US) on a siliFRQZDIHU7KHILUVWOD\HUȝPWKLFN- SU8 3010) 
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IRUPHGWKHPLFURFKDQQHOVȝPORQJȝPZLGHȝPSLWFKFRQQHFWLQJWKHILYH
chambers (1 mm wide, 11-17 mm long), which were obtained through a second layer of resist 
ȝPWKLFN- SU8 3035).  The resist was exposed through a chrome photomask (JD Photo- 
Tools, UK) to UV light and was developed in MicroPosit EC solvent (Rohm and Haas, US).  To 
prevent PDMS adhesion to the resulting silicon master, the silicon surface was silanized by 
vapor deposition of 1H,1H,2H,2H-perfluorooctyl-trichlorosilane (Sigma Aldrich, UK) for 1 
hour.  PDMS was then poured onto the silicon master at a 10:1 ratio of polymer to curing agent, 
degassed and cured at 80°C for at least 3 hours.  The PDMS devices were then peeled from the 
mould, cut to the desired size, and holes were punched (4 mm diameter) to obtain the inlet and 
outlet wells for each chamber.  PDMS devices were cleaned and irreversibly bonded to glass 
coverslips using oxygen plasma.  Bonded devices were then washed with DI water, UV 
sterilized and flooded with a solution of poly-D-O\VLQH3'/ȝJPOIRUKRXUVWRFUHDWHD
suitable adhesion layer within the chambers and microchannels.  Finally, devices were washed 
with Neurobasal-A medium (Life Technologies) prior to cell injection. 
 
Neuronal cell culture 
Hippocampi from 1-3 day old Sprague-Dawley rats of both sexes were dissected and minced.  
Tissue was suspended in filter-sterilized 1.5 mg/ml papain (Sigma Aldrich, UK) in buffer 
comprised of: (mM) 116 NaCl, 5.4 KCl, 26 NaHCO3, 1.3 NaH2PO4, 2 MgSO4, 2 CaCl2, 0.5 
EDTA, and 25 D(+)-glucose, pH 7.4, and incubated at 37 °C for 20 minutes.  Tissue was then 
triturated with a series of 3 flame- polished glass Pasteur pipettes of decreasing tip diameter in 
10 mg/ml bovine serum albumin (Sigma Aldrich, UK) solution (in buffer as above).  The 
resultant cell suspension was spun down and the pellet resuspended in culture medium 
15 
 
consisting of Neurobasal-A Medium supplemented with 2% (v/v) B-27 and 2mM L-glutamine, 
at a density of 3.5 x 106 cells/ml.  Cells were loaded into multi-chamber microfluidic devices 
and incubated in culture medium and maintained in a humidified atmosphere at 37 °C in 5% 
CO2.  ȝORIPHGLXPZDVUHSODFHGLQHDFKZHOOHYHU\-3 days and experiments were 
performed between 15 and 20 days in vitro (DIV 15-20). By DIV 15, hippocampal neurons had 
developed a rich network of processes, expressed functional (Fura-2, AM responses) 
AMPA/kainate and GluN2A and GluN2B NMDA receptors, as determined by the use of 
AMPA/NMDA and selective antagonists (NVP-AAM077 and ifenprodil, respectively).   
 
Immunocytochemistry 
Neuron-seeded devices were stained after DIV 15 to assess the connections between neuronal 
chambers, as previously described(20).  Briefly, cultures within devices were washed with 
phosphate buffered saline (PBS) and fixed in paraformaldehyde (4%, 10 mins).  Cells were then 
washed in PBS and nonspecific binding prevented by incubation in a blocking solution 
containing fetal calf serum (5% v/v) and BSA (1% w/v) and 0.01% Triton-X100 for 30 mins.  
Cells ZHUHZDVKHGZLWK3%6DQGSULPDU\DQWLERGLHVIRU0$3GLOXWLRQDQGȕ-III-
Tubulin (neuron-specific cytoskeletal marker, 1:500 dilution) were diluted into blocking 
solution and incubated with cultures (1 hour).  Cells were then washed with PBS, incubated with 
fluorescently labelled secondary antibodies, and imaged using a cooled CCD digital camera 
(ORCA-ER, Hamamatsu, Japan) and a 40x PL Fluotar oil-immersion objective lens on a Leica 
DM-IRB inverted microscope (both Leica, Germany) using Volocity Acquisition software 
(Improvision, UK). 
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Fluorescence microscopy 
Calcium imaging with Fura-2, AM (Invitrogen) was done as previously described(15). Briefly, 
hippocampal neuron-seeded microfluidic devices were loaded with Fura-$0ȝ0IRU
minutes at 37°C (in the dark) in HEPES-buffered saline (HBS) comprising (mM) 135 NaCl, 5 
KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, and 10 D(+)-glucose (pH 7.4). Devices were washed 
extensively prior to experimentation, and fluorescence monitored using 340 and 380 nm 
excitation filters and a 535 nm emission filter.  Capture rate was set at 5 seconds per time point 
to ensure fast changes in calcium could be detected, and data were analyzed by expressing the 
emission at 535 from excitation at 340 and 380 nm as a ratio, with background subtraction for 
each channel at each time point.  Mitochondrial membrane potential was recorded using 
rhodamine 123 (Invitrogen).  Briefly, hippocampal neuron seeded microfluidic devices were 
LQFXEDWHGZLWKUKRGDPLQHȝJPOLQ+%6LQWKHGDUNDWURRPWHPSHUDWXUHIRU
minutes. Devices were washed and fluorescence monitored using a 492 nm excitation filter and 
a 535 nm emission filter. Regions of interest containing mitochondria were selected posthoc and 
fluorescence intensities measured for each time point. 
 
Neuronal cell death 
Neuron-seeded devices were treated with various pharmacological agents in HBS, as indicated. 
Following treatment, neurons were returned to culture media for 24 hours prior to staining with 
SURSLGLXPLRGLGH3,ȝ0DQG+RHFKVW+RHȝ0IRUPLQXWHV&HOOGHDWKZDV
assessed by counting both dead and live neurons in 6-8 fields of view. Cell death was expressed 
as a percentage of dead cells to total cell number (live + dead) and analyzed. 
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Microfluidic protocol for insult delivery 
To avoid cross-contamination of substances between the chambers and ensure that any toxicity 
spread was solely induced via neuronal network communication across the microchannels, both 
numerical simulations (COMSOL 3.5 ± superimposing the laminar flow and diffusion 
equations) and experimental validation were performed to estimate the optimum condition of 
fluids to be injected in each well of the device. Briefly, prior to insult deliveryȝORI+%6
was injected in every well (maximum volume).  Subsequently, the wells of the addressed 
FKDPEHUZHUHHPSWLHGDQGȝORIH[SHULPHQWDOVROXWLRQ+%6GUXJ was injected in the inlet 
ZHOODQGȝOLQWKHRXWOHWZHOO9ROXPHVZHUHGLVSHQVHGLQȝOVWHSVWRPLQLPL]HVKHDUVWUHVV
RQWKHFHOOVZLWKLQWKHFXOWXUHFKDPEHUV(YHU\IRXUPLQXWHVȝOZDVZLWKGUDZQIURPWKH
RXWOHWZHOODQGȝORIIUHVKH[SHULPHQWDOVROXWLRQZDVUHSODFHGLQWKHLQOHWZHOO7KLV
procedure was carried out continuously for the duration of the experiment, guaranteeing no cross 
contamination to the adjacent chambers. 
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Figure Legends 
Figure 1: Functional synaptic communication between environmentally-isolated neuronal 
networks.  (a) Schematic of the microfluidic device showing the five parallel culture chambers 
(-2, -1, 0, 1, 2). (b) Hippocampal neurons cultured in microfluidic devices labeled to distinguish 
dendrites (MAP2, green) and axons (tubulin, red), with axons crossing the 500 ȝP
microchannels to connect chambers.  (c) Validation of microfluidic protocol for insult delivery. 
(Top) Light microscopy image of the microchannel barrier separating the insulted chamber 
µGLUHFW¶from the insult-free chamber µLQGLUHFW¶. Highlighted circles represent the points of 
fluorescein fluorescence monitoring. (Bottom) Fluorescent intensity profiles obtained from the 
five regions of interest (i-v) using the insult protocol detailed in Materials and Methods. No 
cross contamination of fluorescein was observed in any indirect chambers, whilst an almost 
constant fluorescence profile was achieved across the width of the insulted chamber (circle i). 
(d) A direct excitotoxic challenge (100 GG) leads to delayed Ca2+ deregulation (n = 4) and 
downstream (indirect), activity-dependent (+ TTX, blue traces, n = 3) Ca2+ spiking activity (red 
traces, n = 3). Traces are representative individual neuronal responses (light color) and the mean 
for all recorded cells (dark color). 
 
Figure 2: Glutamate-induced spreading neurotoxicity through neuronal networks. (a) 
Mitochondrial depolarization occurs in neurons directly challenged with excitotoxic glutamate), 
but this does not spread to downstream neurons. (Top) Representative images of rhodamine 123 
fluorescence prior to and following a 100 GG application in chamber 0 (direct). (Bottom) 
Relative change in rhodamine 123 fluorescence in direct (100 GG, black trace) and indirect (red 
trace, n = 4) chambers. Traces are representative individual neuronal responses (light color) and 
the mean for all recorded cells (dark color). (b) Delivery of excitotoxic glutamate to neurons in 
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chamber 0, reveals an activity-dependent spreading toxicity. (Top) Representative PI/Hoechst 
(Hoe.) staining in each neuronal chamber following delivery of excitotoxic glutamate. (Middle) 
Representative MAP2 staining revealing spreading dendrotoxicity following localized 
excitotoxic glutamate. (Bottom) Quantitative change in cell death  following delivery of 
excitotoxic glutamate (100 GG, 1 hour, black arrowhead) to neurons in chamber 0, in the 
DEVHQFHZKLWHEDUVQ DQGSUHVHQFHEODFNEDUVQ RI77;ȝ0 (c) Delivery of 
excitotoxic glutamate to neurons in chamber 0 in the presence of TFB-TBOA (0.ȝ0LQ
chambers -2/-1 (n = 4). (d) Downstream Ca2+ spikes evoked by an indirect excitotoxic challenge 
are blocked by MK 801 ȝ0Q Traces are representative individual neuronal responses 
(light color) and the mean for all recorded cells (dark color). (e) Spreading toxicity to 
downstream chambers is abolished in the presence of downstream MK 801 (n = 4) or (f) 
,IHQSURGLOȝ0 n = 3), but not NVP-$$0ȝ0 n = 3). Basal cell death is indicated 
by the dotted line (UT).  Data are expressed as mean ± S.E.M (one-way ANOVA with post hoc 
7XNH\¶VWHVWµQV¶GHQRWHVS!GHQRWHVSGHQRWHVS 0.01, *** denotes p < 
0.001, relative to control).  
 
Figure 3: Spatiotemporal spreading neuroprotection in connected networks. (a) Direct 
preconditioning (50 GG, 1 hour) of neurons requires 24 hours (50 ± (24h) ± 100) to protect 
against an excitotoxic challenge (100 GG, 1 hour, n = 3) and is activity-dependent (blocked by 
ȝ077;, n = 3). (b) Neurons directly challenged with a preconditioning stimulus (50 GG, 
black trace, n = 3) undergo Ca2+ influx that is mirrored in downstream neurons (red trace, n = 3). 
Traces are representative individual neuronal responses (light color) and the mean for all 
recorded cells (dark color).  (c) Preconditioning (50 GG, 1 hour, grey arrowhead) of neurons in 
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chamber 0 provides protection against spreading toxicity (100 GG, 1 hour, black arrowhead, n = 
4) in downstream chambers (-2, -1, 1 and 2). (d) Neuroprotection against a direct excitotoxic 
insult (100 GG, 1 hour, n = 7) induced by a preconditioning stimulus (50 GG, 1 hour) in 
chamber 0 spreads to downstream neuronal networks (black bars). Spreading neuroprotection 
requires action potentials (blocked by TTX, white bars, n = 3). Protected downstream neurons 
exposed to 100 GG do not (e) undergo excitotoxicity-induced delayed Ca2+ deregulation and 
have significantly reduced peak calcium influx (n = 3) and (f) mitochondrial depolarization (n = 
3). (g) Spreading neuroprotection is abolished in the presence of NVP-$$0ȝ0, n = 3) 
but not Ifenprodil ȝ0, n = 3). Data are expressed as mean ± S.E.M (one-way ANOVA with 
SRVWKRF7XNH\¶VWHVWµQV¶GHQRWHVS!GHQRWHVSGHQRWHVS
denotes p < 0.001, relative to control). 
 
Figure 4: Spreading neuroprotection against a direct excitotoxic challenge requires GABAB 
receptor function. (a) GABAA (muscimol or diazepam) or GABAB (baclofen) receptor activity 
attenuates glutamate excitotoxicity, although prior exposure (60 mins) is required for GABAB 
neuroprotection to develop (n = 3). (b) Spreading toxicity to downstream chambers (-2, -1, 1, 2) 
is blocked by enhancing GABAergic LQKLELWLRQȝ0PXVFLPRO, 5 ȝ0GLD]HSDPor ȝ0
baclofen, n = 3). (c) Downstream Ca2+ spiking spread by an excitotoxic challenge is abolished by 
muscimol or baclofen (n = 3). Traces are representative individual neuronal responses (light 
color) and the mean for all recorded cells (dark color). (d) Spreading neuroprotection from a 
direct excitotoxic challenge (100 GG, 1 hour) is blocked by CGP (n = 3), but not bicuculline (n = 
6). Data are expressed as mean ± S.E.M (one-ZD\$129$ZLWKSRVWKRF7XNH\¶VWHVWµQV¶
denotes p > 0.05, * denotes p < 0.05, ** denotes p <0.01, *** denotes p < 0.001, relative to 
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control). 
 
Figure 5: Temporal profile of spreading neuroprotection . Spreading neuroprotection occurs 
when the protective stimulus is reduced to 30 minutes (a), or when the excitotoxic insult is 
delayed by 1 hour (b). (c) Spreading neuroprotection is lost by 4 hours. (d-f) During an 
excitotoxic challenge (100 GG, black arrowhead), spreading toxicity (white bars, unconditioned 
response, n = 3) is blocked (grey bars, postconditioned response, n = 3) by a distal 
neuroprotective stimulus (50 GG, grey arrowhead) delivered after the excitotoxic challenge. In 
contrast, protection of neurons directly exposed to the excitotoxic challenge occurs after 10 min 
(f) and 30 min (e), but not 60 min (d). Data are expressed as mean ± S.E.M (one way ANOVA 
ZLWKSRVWKRF7XNH\¶VWHVWµQV¶GHQRWHVS!GHQRWHVS denotes p <0.01, *** 
denotes p < 0.001, relative to control). 
 
Figure 6: Spreading neuroprotection from an excitotoxic insult. Neuroprotection against a 
subsequent direct excitotoxic challenge is also spread by an excitotoxic insult (n = 3). Data are 
exprHVVHGDVPHDQ6(0RQHZD\$129$ZLWKSRVWKRF7XNH\¶VWHVWµQV¶GHQRWHVS!
0.05, * denotes p < 0.05, ** denotes p <0.01, *** denotes p < 0.001, relative to control). 
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